Updated from 2:49 p.m. EDT April 8

Widely held health care-related stocks were mostly up Wednesday amid a rally in the broader market.

Eli Lilly ( LLY) shares rose 1.2% to $32.34 Wednesday afternoon after the company, along with Daiichi Sankyo, launched blood-thinner Efient in the U.K. Efient, or prasugrel, was approved in February by European officials to help prevent blood clots in heart patients with stents. It will compete with Plavix, sold by Bristol-Myers Squibb ( BMY) and Sanofi-Aventis ( SNY). Bristol shares rose 1.6% to $20.41. Sanofi-Aventis shares rose 0.5% to $27.71.

Also on the plus side was Merck ( MRK), shares of which rose 1.4% to $26.76.

Among the day's losers:

GlaxoSmithKline ( GSK) shares fell 0.3% to $30.06.

Pfizer ( PFE) shares fell 0.4% to $13.48 in choppy trading.

Procter & Gamble ( PG) shares fell 0.7% to $48.47 after the company said it was cutting about 90 jobs at a plant in Puerto Rico that makes Olay skin care products and Vicks cold medicine.

More from Investing

Harley-Davidson to Shift Some U.S. Production in Wake of Tariffs

Harley-Davidson to Shift Some U.S. Production in Wake of Tariffs

Video: Here's When Investors May Start to Withstand Tough Trade Talk

Video: Here's When Investors May Start to Withstand Tough Trade Talk

Trump Sowing the Seeds of a 10% Stock Market Correction?

Trump Sowing the Seeds of a 10% Stock Market Correction?

5 High-Profile Industrial Stocks Being Rocked By Trade War Fears

5 High-Profile Industrial Stocks Being Rocked By Trade War Fears

How to Play Nvidia and Intel on a Trade War With China

How to Play Nvidia and Intel on a Trade War With China